Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page indicates an updated site revision number (from v3.5.2 to v3.5.3). This reflects a versioning update of the page itself rather than a substantive change to the trial information.
    Difference
    0.1%
    Check dated 2026-04-24T16:48:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2; the previous v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:31:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T09:39:32.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T05:09:42.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The update includes a minor site-version revision (Revision: v3.4.2) and removal of a government-operating-status notice; no study content, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T16:29:28.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A government funding lapse notice was added and the revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:48:12.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.